Daysha Ferrer-Torres

1.3k total citations · 2 hit papers
14 papers, 670 citations indexed

About

Daysha Ferrer-Torres is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daysha Ferrer-Torres has authored 14 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daysha Ferrer-Torres's work include Esophageal Cancer Research and Treatment (6 papers), Cancer-related Molecular Pathways (3 papers) and Epigenetics and DNA Methylation (2 papers). Daysha Ferrer-Torres is often cited by papers focused on Esophageal Cancer Research and Treatment (6 papers), Cancer-related Molecular Pathways (3 papers) and Epigenetics and DNA Methylation (2 papers). Daysha Ferrer-Torres collaborates with scholars based in United States, Spain and Netherlands. Daysha Ferrer-Torres's co-authors include Jason R. Spence, Briana R. Dye, Arend W. Overeem, Lonnie D. Shea, David R. Hill, Alyssa J. Miller, David G. Beer, Andrew C. Chang, Jules Lin and Zhuwen Wang and has published in prestigious journals such as Gastroenterology, Clinical Cancer Research and Nature Protocols.

In The Last Decade

Daysha Ferrer-Torres

13 papers receiving 664 citations

Hit Papers

Generation of lung organoids from human pluripotent stem ... 2019 2026 2021 2023 2019 2023 50 100 150 200 250

Peers

Daysha Ferrer-Torres
Trudy Jonges Netherlands
Quan P. Ly United States
Melisa W-Y. Ho United States
Jon N. Buzzelli Australia
Trudy Jonges Netherlands
Daysha Ferrer-Torres
Citations per year, relative to Daysha Ferrer-Torres Daysha Ferrer-Torres (= 1×) peers Trudy Jonges

Countries citing papers authored by Daysha Ferrer-Torres

Since Specialization
Citations

This map shows the geographic impact of Daysha Ferrer-Torres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daysha Ferrer-Torres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daysha Ferrer-Torres more than expected).

Fields of papers citing papers by Daysha Ferrer-Torres

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daysha Ferrer-Torres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daysha Ferrer-Torres. The network helps show where Daysha Ferrer-Torres may publish in the future.

Co-authorship network of co-authors of Daysha Ferrer-Torres

This figure shows the co-authorship network connecting the top 25 collaborators of Daysha Ferrer-Torres. A scholar is included among the top collaborators of Daysha Ferrer-Torres based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daysha Ferrer-Torres. Daysha Ferrer-Torres is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Ray, Paramita, Sangeeta Jaiswal, Daysha Ferrer-Torres, et al.. (2024). GRAIL1 Stabilizes Misfolded Mutant p53 through a Ubiquitin Ligase-Independent, Chaperone Regulatory Function. Molecular Cancer Research. 22(11). 996–1010.
2.
Sharma, Ankit, Daysha Ferrer-Torres, James Krempski, et al.. (2023). IL-13–induced STAT3-dependent signaling networks regulate esophageal epithelial proliferation in eosinophilic esophagitis. Journal of Allergy and Clinical Immunology. 152(6). 1550–1568. 14 indexed citations
3.
Zhang, Charles J., Matthew J. O’Meara, Sha Huang, et al.. (2023). A human liver organoid screening platform for DILI risk prediction. Journal of Hepatology. 78(5). 998–1006. 108 indexed citations breakdown →
4.
Ray, Paramita, Derek J. Nancarrow, Daysha Ferrer-Torres, et al.. (2021). UBCH5 Family Members Differentially Impact Stabilization of Mutant p53 via RNF128 Iso1 During Barrett’s Progression to Esophageal Adenocarcinoma. Cellular and Molecular Gastroenterology and Hepatology. 13(1). 129–149. 6 indexed citations
5.
Lagisetty, Kiran H., Dyke P. McEwen, Derek J. Nancarrow, et al.. (2020). Immune determinants of Barrett’s progression to esophageal adenocarcinoma. JCI Insight. 6(1). 36 indexed citations
6.
Miller, Alyssa J., Briana R. Dye, Daysha Ferrer-Torres, et al.. (2019). Generation of lung organoids from human pluripotent stem cells in vitro. Nature Protocols. 14(2). 518–540. 297 indexed citations breakdown →
7.
Ray, Dipankar, Paramita Ray, Daysha Ferrer-Torres, et al.. (2019). Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal Cells. Gastroenterology. 158(3). 583–597.e1. 20 indexed citations
8.
Ferrer-Torres, Daysha, Derek J. Nancarrow, Zhuwen Wang, et al.. (2018). Constitutively Higher Level of GSTT2 in Esophageal Tissues From African Americans Protects Cells Against DNA Damage. Gastroenterology. 156(5). 1404–1415. 18 indexed citations
9.
Ferrer-Torres, Daysha, Derek J. Nancarrow, Rork Kuick, et al.. (2016). Genomic similarity between gastroesophageal junction and esophageal Barrett's adenocarcinomas. Oncotarget. 7(34). 54867–54882. 10 indexed citations
10.
Shen, Yu-chi, Stephanie A. Cevallos, Mathew P. Leese, et al.. (2015). Targeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol. British Journal of Cancer. 113(8). 1158–1167. 9 indexed citations
11.
Lin, Jules, Amy L. Myers, Zhuwen Wang, et al.. (2015). Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma. Oncotarget. 6(26). 22239–22257. 55 indexed citations
12.
Myers, Amy L., Lin Lin, Derek J. Nancarrow, et al.. (2015). IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma. Oncotarget. 6(28). 25897–25916. 23 indexed citations
13.
Kausar, Tasneem, Zhuwen Wang, Daysha Ferrer-Torres, et al.. (2014). TGM2: A Cell Surface Marker in Esophageal Adenocarcinomas. Journal of Thoracic Oncology. 9(6). 872–881. 21 indexed citations
14.
Nadal, Ernest, Guoan Chen, Lin Lin, et al.. (2013). Epigenetic Inactivation of microRNA-34b/c Predicts Poor Disease-Free Survival in Early-Stage Lung Adenocarcinoma. Clinical Cancer Research. 19(24). 6842–6852. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026